Publikace
- Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia - Prospective real-time quantitative reverse transcriptase-polymerase chain reaction study2003 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Additional evidence of genetic changes in children with ALL and TEL/AML1 fusion gene2002 | 2. lékařská fakulta
- TEL/AML1 Positivity in Childhood ALL: Average of better Prognosis? Czech Paediatric Haematology Working Group1999 | 2. lékařská fakulta
- FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report2024 | 2. lékařská fakulta
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment2024 | 2. lékařská fakulta
- B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni, 2. lékařská fakulta
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | 2. lékařská fakulta
- TLR8/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins2022 | 1. lékařská fakulta, 2. lékařská fakulta, Matematicko-fyzikální fakulta
- Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK2022 | 2. lékařská fakulta
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia2022 | 2. lékařská fakulta
Loading network view...